References
Albrecht, P., Enis, F. A., Saltzman, E. J., Krugman, S. Persistence of maternal antibody in infants beyond 12 months: mechanisms of measles vaccine failure. J. Pediatrics 91 (1977) 715–718.
Jenks, P. J., Caul, E. O., Roome, A. P. C. H. Maternally derived measles immunity in children of naturally infected and vaccinated mothers. Epidemiol. Infect. 101 (1988) 473–476.
Pannuti, C. S., Moraes, J. C., Souza, V. A. U. F., Camargo, M. C. C., Hidalgo, N. T. R., Brito, G. S., Almeida, M. M., Vielela, M. F. G., Paula, M. C. M. G., Cristiano, E. L. V. C., Stefano, I. A., Sato; H. K. Measles antibody prevalence after mass immunization in Sao Paulo, Brazil. Bull. WHO 69 (1991) 557–560.
Halsey, N. A., Boulous, R., Mode, F., Andre, J., Bowman, L., Yaeger, R. G., Toureau, S., Rhode, J., Boulous, C. Response to measles vaccine in Haitian infants 6 to 12 months old: influence of maternal antibodies, malnutrition and concurrent illness. N. Engl. J. Med. 313 (1985) 544–549.
Kambarami, R. A., Nathoo, K. J., Nkrumah, F. K., Pierie, D. J. Measles epidemic in Harare, Zimbabwe, despite high measles immunization coverage rate. Bull. WHO 69 (1991) 213–219.
Embree, J. E., Datta, P., Stackliw, W., Sekla, L., Braddick, M., Kreiss, J. K., Pamba, H., Wamda, I., Ndinya-Achola, J. O., Law, B. J., Piot, P., Holmes, K. K., Plummer, F. A. Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers. J. Infect. Dis. 165 (1992) 262–267.
Dabis, F., Waldman, R. J., Mann, G. F., Commenges, D., Madzou, G., Jones, T. S. Loss of materal measles antibody during infancy in an African city. Int. J. Epidemiol. 18 (1989) 264–268.
Black, F. L., Berman, L. L., Borgoño, J. M., Capper, R. A., Carvalho, A. A., Collins, C., Glover, O., Hijazi, Z., Jacobson, D. L., Lee, Y-L., Libel, M., Linhares, A. C., Mendizabal-Morris, C. A., Simões, E., Siqueira-Campos, E., Stevenson, J., Vecchi, N. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am. J. Epidemiol. 124 (1986) 442–452.
Puri, S., Chandra, R. K. Nutritional status of host resistance and predictive value of immunological tests in assessment of outcome. Pediatr. Clin. North Am. 32 (1985) 499–516.
Whittle, H., Hanlon, P., O'Neill, K., Hanlon, L., Marsh, V., Jupp, E., Aaby, P. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet ii (1988) 811–814.
Garenne, M., Leroy, O., Beau, J.-P., Sene, I. Child mortality after high-dose measles vaccines: prospective study in Senegal. Lancet 338 (1991) 903–907.
Holt, E. A., Boulos, R., Halsey, N. A., Boulos, L-M., Boulos, C. Childhood survival in Haiti (West Indies): prospective effect of measles vaccination. Pediatrics 85 (1990) 188–194.
Kalter, S. S., Heberling, R. L., Barry, J. D. Detection and titration of measles virus antibody by haemagglutination inhibition and dot immunobinding. J. Clin. Microbiol. 29 (1991) 202–204.
Centers for Disease Control Measles-United States, 1987. MMWR 37 (1988) 527–531.
Onoja, A. L., Adu, F. D., Tomori, O. Evaluation of measles vaccination programme conducted in two separate health centres. Vaccine 10 (1992) 49–52.
Rasmussen, C. M., Thomas, C. W., Mulrooney, R. A. Inadequate poliovirus immunity levels in immunized Illinois children. Am. J. Dis. Child. 126 (1973) 465–469.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arya, S.C. Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition. Infection 21, 256–257 (1993). https://doi.org/10.1007/BF01728906
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01728906